Comparative hydrodynamic evaluation of bioprosthetic heart valves.

نویسندگان

  • S Marquez
  • R T Hon
  • A P Yoganathan
چکیده

BACKGROUND AND AIM OF STUDY Pressure gradients across cardiac valve prostheses have been identified as one of the most important performance measures in valve replacement surgery. Specifically in aortic valves, these gradients influence reduction of left ventricular hypertrophy and are postulated to influence long-term survival. The correct choice of replacement valve is hampered by a lack of uniform measures of valve performance. The aim of this study was to compare in-vitro hydrodynamic performance of commercially available bioprosthetic valves under identical test conditions. METHODS In-vitro steady forward flow and pulsatile flow tests were performed on aortic and mitral bioprosthetic valves in accordance with ISO/FDA guidelines at two different institutions to obtain objective hemodynamic performance measures. Measurements were recorded at various flow rates, flow and pressure to obtain mean pressure gradients and effective orifice areas (EOAs). RESULTS Wide variation in pressure gradients was found among tested valves of each size. For a given size, differences of 200 to 400% were observed; in general, the valve models' relative rankings in pressure drop were independent of size. CONCLUSION The Carpentier-Edwards Perimount valve showed superior performance at all sizes tested. While the mean pressure gradients and EOAs reported by each institution differed for a given valve, the performance of valve models relative to each other was similar. The testing of valves under identical conditions is a valuable comparative indicator of valve hemodynamic performance.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Degenerative processes in bioprosthetic mitral valves in juvenile pigs

BACKGROUND Glutaraldehyde-treated bioprosthetic heart valves are commonly used for replacement of diseased heart valves. However, calcification and wear limit their durability, and the development of new and improved bioprosthetic valve designs is needed and must be evaluated in a reliable animal model. We studied glutaraldehyde-treated valves 6 months after implantation to evaluate bioprosthet...

متن کامل

Short-term performance of mitral valve replacement with porcine bioprosthetic valves in dogs.

Porcine bioprosthetic valves cross-linked with glutaraldehyde and polyepoxy compound were newly developed for mitral valve replacement (MVR) in dogs. Five beagle dogs were performed a left thoracotomy and underwent MVR using the porcine bioprosthetic valves during cardiopulmonary bypass (CPB). A vein catheter inserted into right atrium and a vent catheter inserted into the right ventricle to dr...

متن کامل

Trans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experience)

Introduction: With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the ...

متن کامل

Thrombogenic potential of Innovia polymer valves versus Carpentier-Edwards Perimount Magna aortic bioprosthetic valves.

Trileaflet polymeric prosthetic aortic valves (AVs) produce hemodynamic characteristics akin to the natural AV and may be most suitable for applications such as transcatheter implantation and mechanical circulatory support (MCS) devices. Their success has not yet been realized due to problems of calcification, durability, and thrombosis. We address the latter by comparing the platelet activatio...

متن کامل

Is it the time to reconsider the choice of valves for cardiac surgery: mechanical or bioprosthetic?

Valvular heart disease is a pathologic process involving one or more of the four valves (aortic, pulmonary, mitral and tricuspid) of the heart typified by stenosis or regurgitation and leading to patient symptoms. The most common causes are tissue degeneration, rheumatic fever and congenital heart diseases. Aortic valve replacement (AVR) using either mechanical or bioprosthetic (tissue) valves ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Journal of heart valve disease

دوره 10 6  شماره 

صفحات  -

تاریخ انتشار 2001